Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1285-1292

  Li, Chong ^a   Zhang, Xiaolin ^a   Huang, Xinliang ^a   Wang, Xiaoying ^a   Liao, Guojian ^a   Chen, Zhangbao ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Biofilm; Daptomycin; Liposomes; Response surface methodology

Indexed keywords

CHOLIC ACID; DAPTOMYCIN; LIPID; LIPOSOME; PHOSPHATIDYLCHOLINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERIAL SKIN DISEASE; BIOFILM; CONTROLLED STUDY; DISPERSION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PENETRATION; DRUG TISSUE LEVEL; ENCAPSULATION; HYDRATION; LIGHT SCATTERING; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PARTICLE SIZE; RESPONSE SURFACE METHOD; SKIN PENETRATION; STAPHYLOCOCCUS AUREUS; TEMPERATURE; ULTRASOUND; ZETA POTENTIAL;

BIOFILM; DAPTOMYCIN; LIPOSOMES; RESPONSE SURFACE METHODOLOGY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DAPTOMYCIN; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; NANOPARTICLES; PARTICLE SIZE; RANDOM ALLOCATION; SKIN; SKIN ABSORPTION; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84875492526     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S41695     Document Type: Article

References (26)

1. Kirkpatrick P, Raja A, LaBonte J, Lebbos J. Daptomycin. Nat Rev Drug Discov. 2003;2:943-944.
2. Kirsch LE, Molloy RM, Debono M, et al. Kinetics of the aspartyl transpeptidation of daptomycin, a novel lipopeptide antibiotic. Pharm Res. 1989;6:387-393.
3. Patel D, Husain M, Vidaillac C, et al. Mechanisms of in vitro-selected daptomycin - non-susceptibility in Staphylococcus aureus. Int J Antimicrob Agents. 2011;38:442-446.
4. Alborn WE, Allen NE, Preston DA. Daptomycin disrupts membrane potential in growing Staphyococcus aureus. Antimicrob Agents Chemother. 1991;35:2282-2287.
5. Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. Arch Dermatol Res. 1990;7:479-489.
6. Verma DD, Verma S, Blume G, et al. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm. 2003;55:271-277.
7. Verma DD, Verma S, Blume G, et al. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258: 141-151.
8. Cerc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104:226-232.
9. Cevc G, Schatzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002;1564:21-30.
10. Cevc G, Blume G, Schatzlein A. Transfersome-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211-226.
11. Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta. 2001;1514:191-205.
12. Singodia D, Gupta GK, Verma A, et al. Development and performance evaluation of amphotericin B transfersomes against resistant and sensitive clinical isolates of visceral leishmaniasis. J Biomed Nanotechnol. 2010;6:293-302.
13. Masako K, Hideyuki I, Shigeyuki O, et al. A novel method to control the balance of skin mecroflora. Part 1. Attack biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci. 2005;38:197-205.
14. Tobin CM, Darville JM, Lovering AM, et al. An HPLC assay for daptomycin in serum. J Antimicrob Chemother. 2008;62:1462-1476.
15. Verdier MC, Bentue-Ferrer D, Tribut O, et al. Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application. Clin Chem Lab Med. 2011;49:69-75.
16. Nayak AK, Mohanty B, Sen KK. Comparative evaluation of in vitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles. International Journal of Pharm Tech Research. 2010;2:920-930.
17. Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011;2011:418316.
18. Schinabeck MK, Long LA, Hossain MA, et al. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother. 2004;48:1727-1732.
19. Chicurel M. Slimebusters. Nature. 2000;408:284-286.
20. Ghiselli R, Giacometti A, Goffi L, et al. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. J Surg Res. 2001;99:316-320.
21. Sader HS, Jones RN. Antimicrobial susceptibility of Gram-positive bacteria from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis. 2009;65: 158-162.
22. Lambert WJ. Drug delivery: what the future holds. Bio Pharm Int. 2007;20:32-39.
23. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2007;22:659-661.
24. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther. 2003;1:667-683.
25. Roveta S, Marchese A, Schito GC. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents. 2008;31:321-328.
26. Jones MN. Use of liposomes to delivery bactericides to bacterial biofilms. Methods Enzymol. 2005;391:211-228.